STUDY ON THE CORRELATION BETWEEN LEFT VENTRICULAR DIASTIC DYSFUNCTION AND BLOOD CORTISOL CONCENTRATION IN TYPE 2 DIABETES PATIENTS

Thi Ngoc Hien Huynh1,, Thi Kim Chau Doan2, Ngoc Dai Trang Nguyen1, Dai Phuc Le1, Thi Ngoc Han Nguyen2
1 Can Tho Central General Hospital
2 Can Tho University of Medicine and Phamarcy

Main Article Content

Abstract

Background: Cardiovascular complications in patients with type 2 diabetes need to be detected early and left ventricular dysfunction is early myocardial damage that progresses to heart failure. Objectives: 1) To investigate the prevalence of LVDD and some factors related to LVDD. 2) To estimate plasma cortisol concentration in LVDD patients. 3) To determine the correlation between plasma cortisone levels and LVDD. Materials and methods: A cross-sectional descriptive study was conducted on 80 inpatients with type 2 diabetes from 40-70 years old, at the Department of Endocrinology, Can Tho Central General Hospital from September 2022 to May 2023. Results: The rate of LVDD in patients with type 2 diabetes was 26.3%, grade I accounted for 33.3%, grade II (38.1%), and grade III (28.6%). The group with microalbuminuria had a higher risk of LVDD about 3.7 times higher than the normal group (OR: 3.7, p<0.05). Blood cortisol levels in patients with LVDD were much higher (median value was 19.7 versus 8.2), the difference was statistically significant (p<0.01). Plasma cortisol levels had statistically significant positive correlations with the E/e’ ratio in ultrasound with the coefficient correlation of 0.48 (p<0.01). Conclusions: Patients with type 2 diabetes with elevated blood cortisone may be at risk of LVDD and other factors such as microalbuminuria, diabetes duration, and age are also related to severity of LVDD. Plasma cortisol concentrations in type 2 diabetes mellitus group with left ventricular diastolic dysfunction were higher than in type 2 diabetes mellitus patients without left ventricular diastolic dysfunction.

Article Details

References

1. Kenny, H.C. and Abel, E.D., Heart Failure in Type 2 Diabetes Mellitus. Circ Res, 2019. 124(1):
p. 121-141. Doi: 10.1161/circresaha.118.311371
2. McAllister, D.A., Read, S.H., Kerssens, J., Livingstone, S., McGurnaghan, S., et al., Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and
Without Diabetes Mellitus. Circulation, 2018. 138(24): p. 2774-2786. Doi: 10.1161/circulationaha.118.034986
3. Güder, G., Bauersachs, J., Frantz, S., Weismann, D., Allolio, B., et al., Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation, 2007. 115(13): p. 1754-61. Doi: 10.1161/circulationaha.106.653964
4. American Diabetes Association Professional Practice Committee, 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care, 2022. 45(Suppl 1): p. S17-s38. Doi: 10.2337/dc22-S002
5. Nagueh, S.F., Smiseth, O.A., Appleton, C.P., Byrd, B.F., 3rd, Dokainish, H., et al.,
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the
European Association of Cardiovascular Imaging. J Am Soc Echocardiogr, 2016. 29(4): p. 277314. Doi: 10.1016/j.echo.2016.01.011
6. Nguyễn Thu Hiền, Phạm Thanh Tùng, and Khảo sát tỷ lệ rối loạn chức năng tâm trương thất trái ở bệnh nhân đái tháo đường típ 2. Vietnam Journal of Diabetes Endocrinology (44), 2021. 44: p. 43-48. Doi,
7. Johansson, I., Dahlström, U., Edner, M., Näsman, P., Ryden, L., et al., Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function. 2018. 15(6): p. 494-503. Doi,
8. Nguyễn Thị Tuyết Hằng and Nguyễn Thị Hậu, Khảo Sát Rối Loạn Chức Năng Tâm Trương
Thất Trái Trên Bệnh Nhân Bệnh Cơ Tim Do Đái Tháo Đường Týp 2. Tạp Chí Y Học TP. Hồ Chí Minh, 2013. 17(1): p. 629-630. Doi,
9. Sagara, R., Inoue, T., Sonoda, N., Yano, C., Motoya, M., et al., Association between cortisol and left ventricular diastolic dysfunction in patients with diabetes mellitus. J Diabetes Investig, 2022. 13(2): p. 344-350. Doi: 10.1111/jdi.13653.